Dressler's syndrome: Difference between revisions

Jump to navigation Jump to search
 
(116 intermediate revisions by 12 users not shown)
Line 1: Line 1:
{{DiseaseDisorder infobox |
__NOTOC__
  Name          = {{PAGENAME}} |
{{SI}}
  ICD10          = {{ICD10|I|24|1|i|20}} |
'''For patient information click [[Dressler's syndrome (patient information)|here]]'''
  ICD9          = {{ICD9|411.0}} |
  ICDO          = |
  Image          = |
  Caption        = |
  OMIM          = |
  MedlinePlus    = |
  eMedicineSubj  = |
  eMedicineTopic = |
  DiseasesDB    = 3947 |
}}


{{Pericarditis}}
{{CMG}}; {{AE}} {{AIA}}; [[User: Mohammed Sbeih|Mohammed A. Sbeih, M.D.]][mailto:msbeih@wikidoc.org]; {{CZ}}; {{NA}}
{{SI}}


{{CMG}}; '''Associate Editor-In-Chief:''' [[User: Mohammed Sbeih|Mohammed A. Sbeih, M.D.]][mailto:msbeih@perfuse.org] Phone:617-849-2629; {{CZ}}
{{SK}} Postmyocardial infarction syndrome; PMIS; Post-cardiac injury syndrome
 
'''''Synonyms and keywords:''''' Postmyocardial infarction syndrome, post MI pericarditis, PMIS


==Overview==
==Overview==
'''Dressler's syndrome''' or post myocardial infarction syndrome is a form of [[pericarditis]] that occurs in the setting of injury to the [[heart]] as a result of myocardial infarction<ref name="pmid5039567">{{cite journal |author=Hutchcroft BJ |title=Dressler's syndrome |journal=Br Med J |volume=3 |issue=5817 |pages=49 |year=1972 |month=July |pmid=5039567 |pmc=1788531 |doi= |url=}}</ref>. Dressler's syndrome typically occurs 2 to 10 weeks after myocardial infarctionit's<ref>{{cite journal | author = Krainin F, Flessas A, Spodick D | title = Infarction-associated pericarditis. Rarity of diagnostic electrocardiogram. | journal = N Engl J Med | volume = 311 | issue = 19 | pages = 1211-4 | year = 1984 | id = PMID 6493274}}</ref>.  This differentiates Dressler's syndrome from the much more common post myocardial infarction pericarditis which occurs between days 2 and 4 after myocardial infarction.
Dressler's syndrome or post-myocardial infarction syndrome is a form of [[pericarditis]] that occurs in the setting of [[myocardial infarction]]. It typically occurs 2 to 10 weeks after [[myocardial infarction]]. Dressler's syndrome results from an [[autoimmune]] [[Inflamation|inflammatory reaction]] to [[Myocardium|myocardial]] [[Antigens|neo-antigens]]. Possible complications include [[pericardial effusion]], [[cardiac tamponade]], and [[constrictive pericarditis]]; however, the prognosis is usually favorable with early treatment. The diagnostic criteria of Dressler's syndrome depend on pleuritic [[chest pain]], [[pericardial friction rub]], ECG changes, and [[echocardiography]]-detected [[pericardial effusion]]. The recommended medical treatments include [[aspirin]] and [[colchicine]].  


==Historical Perspective==
==Historical Perspective==
It was first characterized by William Dressler in 1956.<ref name="pmid13306560">{{cite journal| author=DRESSLER W| title=A post-myocardial infarction syndrome; preliminary report of a complication resembling idiopathic, recurrent, benign pericarditis. | journal=J Am Med Assoc | year= 1956 | volume= 160 | issue= 16 | pages= 1379-83 | pmid=13306560 | doi= | pmc= | url= }} </ref>.<ref name="pmid15539743">{{cite journal |author=Bendjelid K, Pugin J |title=Is Dressler syndrome dead? |journal=Chest |volume=126 |issue=5 |pages=1680–2 |year=2004 |month=November |pmid=15539743 |doi=10.1378/chest.126.5.1680 |url=http://www.chestjournal.org/cgi/pmidlookup?view=long&pmid=15539743}}</ref><ref name="pmid6728756">{{cite journal |author=Streifler J, Pitlik S, Dux S, ''et al'' |title=Dressler's syndrome after right ventricular infarction |journal=Postgrad Med J |volume=60 |issue=702 |pages=298–300 |year=1984 |month=April |pmid=6728756 |pmc=2417818 |doi= |url=}}</ref><ref name="pmid13605300">{{cite journal |author=Dressler W |title=The post-myocardial-infarction syndrome: a report on forty-four cases |journal=AMA Arch Intern Med |volume=103 |issue=1 |pages=28–42 |year=1959 |month=January |pmid=13605300 |doi= |url=}}</ref>


It should not be confused with the Dressler's syndrome of [[haemoglobinuria]] named for Lucas Dressler, who characterized it in 1854.<ref>{{WhoNamedIt|synd|3982}}</ref><ref>L. A. Dressler. Ein Fall von intermittirender Albuminurie und Chromaturie. Archiv für pathologische Anatomie und Physiologie und für klinische Medicin, 1854, 6: 264-266. </ref>
* Dressler's syndrome was first characterized by William Dressler in 1956.
* It should not be confused with the Dressler's syndrome of [[hemoglobinuria]], named after Lucas Dressler who characterized it in 1854.<ref>{{WhoNamedIt|synd|3982}}</ref><ref>L. A. Dressler. Ein Fall von intermittirender Albuminurie und Chromaturie. Archiv für pathologische Anatomie und Physiologie und für klinische Medicin, 1854, 6: 264-266. </ref><ref name="pmid13306560">{{cite journal| author=DRESSLER W| title=A post-myocardial infarction syndrome; preliminary report of a complication resembling idiopathic, recurrent, benign pericarditis. | journal=J Am Med Assoc | year= 1956 | volume= 160 | issue= 16 | pages= 1379-83 | pmid=13306560 | doi= | pmc= | url= }} </ref>
 
==Classification==
 
* There is no established system for the classification of Dressler's syndrome.


==Pathophysiology==
==Pathophysiology==
Dressler's syndrome is believed to result from an [[autoimmune]] inflammatory reaction to myocardial neo-[[antigen]]s. It usually occurs within weeks or months of the Infarction due to antiheart antibodies, this begins with myocardial injury that releases cardiac antigens and stimulates antibody formation. The immune complexes that are generated then deposit onto the pericardium and causes the inflamation. The autoimmune response and syndrome may also appear after [[pulmonary embolism]] <ref name="pmid8759817">{{cite journal| author=Jerjes-Sánchez C, Ramírez-Rivera A, Ibarra-Pérez C| title=The Dressler syndrome after pulmonary embolism. | journal=Am J Cardiol | year= 1996 | volume= 78 | issue= 3 | pages= 343-5 | pmid=8759817 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8759817  }} </ref>.
 
* Although the exact cause remains unknown, Dressler's syndrome is believed to result from an [[autoimmune]] [[Inflamation|inflammatory reaction]] to [[Myocardium|myocardial]] [[Antigens|neo-antigens]], as well as injury to the [[Mesothelium|mesothelial]] [[pericardial]] [[Cell (biology)|cells]].<ref name="pmid785768">{{cite journal| author=Engle MA, Zabriskie JB, Senterfit LB| title=Heart-reactive antibody, viral illness, and the postpericardiotomy syndrome. Correlates of a triple-blind, prospective study. | journal=Trans Am Clin Climatol Assoc | year= 1976 | volume= 87 | issue=  | pages= 147-60 | pmid=785768 | doi= | pmc=2441394 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=785768  }}</ref>
* It usually occurs within weeks or months of the [[infarction]] due to antimyocardial [[antibodies]]; this begins with [[myocardial injury]] that releases [[Heart|cardiac]] [[Antigen|antigens]] and stimulates [[antibody]] formation.
* The [[immune complexes]] that are generated as anti-[[actin]] and [[actomyosin]] [[antibodies]] deposit onto the [[pericardium]] and causes [[inflammation]].
* The [[Autoimmunity|autoimmune response]] and [[syndrome]] may also develop [[secondary]] to [[pulmonary embolism]].<ref name="pmid8759817">{{cite journal| author=Jerjes-Sánchez C, Ramírez-Rivera A, Ibarra-Pérez C| title=The Dressler syndrome after pulmonary embolism. | journal=Am J Cardiol | year= 1996 | volume= 78 | issue= 3 | pages= 343-5 | pmid=8759817 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8759817  }} </ref>
 
===Gross Pathology===
[[Gross examination|Gross]] [[pathological]] [[examination]] may show the following findings: <ref name="pmid26240567">{{cite journal| author=Feola A, De Stefano N, Della Pietra B| title=Pericarditis Epistenocardica or Dressler Syndrome? An Autopsy Case. | journal=Case Rep Med | year= 2015 | volume= 2015 | issue=  | pages= 215340 | pmid=26240567 | doi=10.1155/2015/215340 | pmc=4512600 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26240567  }}</ref>
 
* Fine granular layer on the [[epicardial]] surface with a “[[bread]] and [[butter]]” appearance.
*Because Dressler's syndrome is more common with transmural [[Infarction|infarctions]], the causing [[infarction]] is likely to be seen.
 
[[File:CRIM2015-215340.001.jpg|center|thumb|The epicardium was characterized by a fine granular layer on its surface with a “bread and butter” appearance, particularly at the level of the atrial regions and the cardiac apex in a case of Dressler's syndrome. <ref>https://www.hindawi.com/journals/crim/2015/215340/fig1//</ref>]]
<br />
=== Microscopic Pathology ===
[[Microscopic]] [[examination]] of the [[Myocardium|myocardial]] [[Tissue (biology)|tissue]] sections may show: <ref name="pmid262405672">{{cite journal| author=Feola A, De Stefano N, Della Pietra B| title=Pericarditis Epistenocardica or Dressler Syndrome? An Autopsy Case. | journal=Case Rep Med | year= 2015 | volume= 2015 | issue=  | pages= 215340 | pmid=26240567 | doi=10.1155/2015/215340 | pmc=4512600 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26240567  }}</ref>
 
* Plurifocal signs of [[Myocardium|myocardial]] [[sclerosis]] may be detected.
*[[Lymphocytic]] perimyofibrillar microinfiltrations may be seen.
*Localized [[lipofuscin]] [[pigment]] deposits in the [[myocytes]].


==Causes==
==Causes==
*[[Coronary artery bypass grafting]]
The common causes of Dressler's syndrome include: <ref name="pmid28723017">{{cite journal| author=| title=StatPearls | journal= | year= 2019 | volume=  | issue=  | pages=  | pmid=28723017 | doi= | pmc= | url= }}</ref>
*[[Myocardial infarction]] ([[heart attack]])
 
*[[Surgery|Surgeries]] associated with [[Myocardium|myocardial]] damage
**[[Coronary artery bypass grafting]] and
**Aortic valve replacement.
*[[Myocardial infarction]]
*[[Pulmonary embolism]]
*[[Pulmonary embolism]]


==Conditions that Dressler's Syndrome should be Differentiated From==
==Differentiating Dressler's Syndrome from other Diseases==
Dressler's syndrome typically occurs 2 to 10 weeks after a myocardial infarction has occurred<ref>{{cite journal | author = Krainin F, Flessas A, Spodick D | title = Infarction-associated pericarditis. Rarity of diagnostic electrocardiogram. | journal = N Engl J Med | volume = 311 | issue = 19 | pages = 1211-4 | year = 1984 | id = PMID 6493274}}</ref>. This differentiates Dressler's syndrome from the much more common post myocardial infarction pericarditis that occurs in 17 to 25% of cases of acute myocardial infarction between days 2 and 4 after the myocardial infarction. Dressler's syndrome also needs to be differentiated from [[pulmonary embolism]], another identifiable cause of [[pleuritic]] (and non-pleuritic) [[chest pain]] in people who have been hospitalized and/or undergone surgical procedures within the preceding weeks.
 
* Dressler's syndrome typically occurs 2 to 10 weeks after a [[myocardial infarction]] has occurred.<ref name=":0">{{cite journal | author = Krainin F, Flessas A, Spodick D | title = Infarction-associated pericarditis. Rarity of diagnostic electrocardiogram. | journal = N Engl J Med | volume = 311 | issue = 19 | pages = 1211-4 | year = 1984 | id = PMID 6493274}}</ref><ref>{{cite journal | author = Krainin F, Flessas A, Spodick D | title = Infarction-associated pericarditis. Rarity of diagnostic electrocardiogram. | journal = N Engl J Med | volume = 311 | issue = 19 | pages = 1211-4 | year = 1984 | id = PMID 6493274}}</ref>
* This differentiates Dressler's syndrome from:
 
**[[Post myocardial infarction pericarditis]] that occurs in 17,000 to 25,000 in every 100,000 cases of [[acute myocardial infarction]] between days 2 and 4 after the [[ST elevation myocardial infarction|myocardial infarction.]]
 
**[[Pulmonary embolism]], another identifiable cause of [[pleuritic]] (and non-[[pleuritic]]) [[chest pain]] in people who have been [[Hospitalization|hospitalized]] and/or undergone [[Surgical procedure|surgical procedures]] within the preceding weeks.
 
* Dressler's syndrome should be differentiated from:
 
**[[Congestive Heart Failure]]: Another complication of MI that may occur in a more acute setting.
**Acute [[anemia]] (e.g., [[hemorrhage]]): shares the same [[Symptom|symptoms]] as [[malaise]], [[dyspnea]], and [[Palpitation|palpitations]].
**[[Uremia]]: may lead to pericarditis that must be differentiated from Dressler's syndrome.


==Epidemiology and Demographics==
==Epidemiology and Demographics==
In the setting of myocardial infarction, Dressler's syndrome occurs in about 7% of cases<ref>{{cite journal | author = Krainin F, Flessas A, Spodick D | title = Infarction-associated pericarditis. Rarity of diagnostic electrocardiogram. | journal = N Engl J Med | volume = 311 | issue = 19 | pages = 1211-4 | year = 1984 | id = PMID 6493274}}</ref>.  Dressler's syndrome was more commonly seen in the era prior to [[reperfusion]], but its incidence has markedly decreased in the reperfusion era, presumably because of smaller infarct sizes <ref name="pmid2643287">{{cite journal| author=Tofler GH, Muller JE, Stone PH, Willich SN, Davis VG, Poole WK et al.| title=Pericarditis in acute myocardial infarction: characterization and clinical significance. | journal=Am Heart J | year= 1989 | volume= 117 | issue= 1 | pages= 86-92 | pmid=2643287 | doi= | pmc= | url= }} </ref>.
 
*[[Incidence]]: In the setting of [[ST elevation myocardial infarction|myocardial infarction]], Dressler's syndrome was classically reported to occur in about 3 to 4% of [[MI]] cases.<ref>{{cite journal | author = Krainin F, Flessas A, Spodick D | title = Infarction-associated pericarditis. Rarity of diagnostic electrocardiogram. | journal = N Engl J Med | volume = 311 | issue = 19 | pages = 1211-4 | year = 1984 | id = PMID 6493274}}</ref>
*However, the [[incidence]] has markedly decreased in the [[reperfusion]] era (between 0.5 to 2%), presumably because of smaller [[Infarction|infarct]] sizes.<ref name="pmid2643287">{{cite journal| author=Tofler GH, Muller JE, Stone PH, Willich SN, Davis VG, Poole WK et al.| title=Pericarditis in acute myocardial infarction: characterization and clinical significance. | journal=Am Heart J | year= 1989 | volume= 117 | issue= 1 | pages= 86-92 | pmid=2643287 | doi= | pmc= | url= }} </ref>
*Age: Dressler's syndrome occurs more often in younger age groups.
*Gender: There is no gender predilection for Dressler's syndrome.
*Race: There is no racial predilection for Dressler's syndrome.
*[[Mortality rate]]: The [[prognosis]] is usually favorable with early treatment with a low [[mortality rate]].
 
==Risk Factors==
 
* The risk of Dressler's syndrome increases with the size of the [[infarction]].
* Further, a former episode of Dressler's syndrome increases the risk of [[relapse]] upon recurrent [[ST elevation myocardial infarction|MI]] (the most important [[risk factor]]).
*[[Epidemiology|Epidemiological]] studies showed a higher risk ratio of Dressler's syndrome with: <ref name="pmid287230172">{{cite journal| author=| title=StatPearls | journal= | year= 2019 | volume=  | issue=  | pages=  | pmid=28723017 | doi= | pmc= | url= }}</ref>
 
**[[Cardiac surgery|Cardiac surgeries]] associated with greater [[Myocardium|myocardial]] damage as [[aortic valve replacement]]
** Younger age
** Prior treatment with [[prednisone]]
** B-negative [[blood type]]
**[[Halothane]] [[anesthesia]]
**[[Virus|Viral infections]] that have been associated with Dressler's syndrome (based on the seasonal variations in [[incidence]] and elevated [[blood]] levels of [[Virus|viral]] components in [[Dressler's syndrome (patient information)|Dressler's Syndrome]] [[Patient|patients]]), including: <ref name="pmid7857682">{{cite journal| author=Engle MA, Zabriskie JB, Senterfit LB| title=Heart-reactive antibody, viral illness, and the postpericardiotomy syndrome. Correlates of a triple-blind, prospective study. | journal=Trans Am Clin Climatol Assoc | year= 1976 | volume= 87 | issue=  | pages= 147-60 | pmid=785768 | doi= | pmc=2441394 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=785768  }}</ref>
***[[Coxsackie B virus]]
***[[Adenovirus]]
***[[Cytomegalovirus]]
 
==Screening==
 
* There is insufficient evidence to recommend routine [[Screening (medicine)|screening]] for Dressler's syndrome.
 
==Natural History, Complications, and Prognosis==
 
=== Natural History ===
 
* Dressler's syndrome typically occurs 2 to 10 weeks after a [[myocardial infarction]] has occurred.<ref name=":0" />
* The [[Symptom|symptoms]] for Dressler's syndrome starts mild and then progress to reach the full clinical profile.
* The condition is usually [[Acute (medicine)|acute]]; however, some [[Patient|patients]] may develop [[Chronic (medical)|chronic]] [[pericardial]] [[inflammation]].
* The [[prognosis]] is usually favorable with early treatment.
* Untreated or poorly treated [[Patient|patients]] may develop [[cardiac tamponade]] ([[Acute (medicine)|acute]]) or [[constrictive pericarditis]] ([[Chronic (medical)|chronic]]).
 
=== Complications ===
The [[Complication (medicine)|complications]] of Dressler's syndrome may include: <ref name="pmid287230173">{{cite journal| author=| title=StatPearls | journal= | year= 2019 | volume=  | issue=  | pages=  | pmid=28723017 | doi= | pmc= | url= }}</ref>
 
*[[Pericardial effusion]] may result from the accumulation of [[fluids]] as a result of [[inflammation]] in the [[pericardial sac]].
*[[Cardiac tamponade]] can occur if the accumulation of [[Fluid|fluids]] in the [[pericardium]] is large enough and rapid enough.
*[[Constrictive pericarditis]] can occur if there is a [[Chronic inflammation|chronic inflammatory]] response.
 
=== Prognosis ===
 
* The [[prognosis]] for patients with Dressler's syndrome is usually favorable, even those requiring [[Pericardiocentesis|pericardial drainage]].
* However, the latter [[Patient|patients]] have a higher risk for [[fluid]] reaccumulation and repeat [[pericardiocentesis]].  
* Otherwise, [[constrictive pericarditis]] would occur leading to the need for [[pericardial stripping]].


==Diagnosis==
==Diagnosis==
===Symptoms===
 
The syndrome consists of a persistent low-grade [[fever]], and [[chest pain]] which is usually [[pleuritic]] in nature. The symptoms tend to occur after a few weeks or even months after [[myocardial infarction]] and tend to subside in a few days.
=== Diagnostic Study of Choice ===
'''"2017 Revised ESC Guidelines for the Management of ST-Elevation Myocardial Infarction (DO NOT EDIT)'''
 
Diagnostic criteria do not differ from those for acute pericarditis including two of the following criteria: (i) pleuritic chest pain (85–90% of cases); (ii) pericardial friction rub (≤ 33% of cases); (iii) ECG changes (≤ 60% of cases), with new widespread ST-segment elevation, usually mild and progressive, or PR depression in the acute phase; and (iv) pericardial effusion (≤ 60% of cases and generally mild)".<ref name="pmid28886621">{{cite journal| author=Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H et al.| title=2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). | journal=Eur Heart J | year= 2018 | volume= 39 | issue= 2 | pages= 119-177 | pmid=28886621 | doi=10.1093/eurheartj/ehx393 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28886621  }}</ref>
 
===History and Symptoms===
The syndrome consists of a persistent low-grade [[fever]] and [[chest pain]] which is usually [[pleuritic]] in nature.The symptoms enlisted below tend to occur after a few weeks or even months after [[myocardial infarction]] and tend to subside in a few days: <ref name="pmid165531112">{{cite journal| author=Wessman DE, Stafford CM| title=The postcardiac injury syndrome: case report and review of the literature. | journal=South Med J | year= 2006 | volume= 99 | issue= 3 | pages= 309-14 | pmid=16553111 | doi=10.1097/01.smj.0000203330.15503.0b | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16553111  }}</ref>
 
*[[Malaise]]
*[[Irritability]]
*[[Anorexia|Lack of appetite]]
*[[Dyspnea|Difficulty breathing]] (with or without [[hypoxia]])
*[[Palpitations]]
*[[Arthralgias|Pain in the joints]]
*


===Physical Examination===
===Physical Examination===
====Cardiovascular Examination====
[[Physical examination]] of patients with Dressler's syndrome may show<ref name="pmid287230173" />:
A [[pericardial friction rub]], and /or a [[pericardial effusion]] is present.  
 
*[[Pericardial friction rub]]: This characteristic sign may disappear secondary to either improvement in or worsening of accumulation of pericardial fluid
*[[Tachycardia]]
*[[Pulsus paradoxus]] (>10 mmHg decrease in blood pressure with inspiration and decreased pulse amplitude on the [[radial artery]]).
*Signs of [[pneumonitis]] (e.g., a cough, decreased oxygen saturation, and fever).
*Minimal respiratory symptoms to significant [[respiratory distress]] with large [[Pleural effusion|pleural effusions]].


===Laboratory Findings===
===Laboratory Findings===
Elevated [[Erythrocyte sedimentation rate|ESR]].
The laboratory work-up of patients with Dressler's syndrome may include: <ref name="pmid287230173" />
 
* [[Blood culture]]: can differentiate between [[Inflammation|inflammatory]] and [[Infection|infectious]] [[pericarditis]] (should be negative in Dressler's syndrome)
 
* [[Leukocytosis|Leucocytosis]] (with a leftward shift)
* Elevated [[acute phase reactant]]<nowiki/>[[acute phase reactant|s]] (e.g., [[Erythrocyte sedimentation rate|ESR]] and [[C-reactive protein|CRP]])
* High serum titers of anti-cardiac antibodies
* The [[pericardial fluid]] may be examined for cell count, culture, [[Serum total protein|total protein]]<nowiki/>s, and [[triglyceride]] levels
 
=== Electrocardiogram ===
An ECG may demonstrate: <ref name="pmid24062911">{{cite journal| author=Hendry C, Liew CK, Chauhan A, Zacharias J| title=A life-saving case of Dressler's syndrome. | journal=Eur Heart J Acute Cardiovasc Care | year= 2012 | volume= 1 | issue= 3 | pages= 232-5 | pmid=24062911 | doi=10.1177/2048872612452319 | pmc=3760538 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24062911  }}</ref>
 
*[[ST segment elevation]]
*[[T wave inversion|T-wave inversion]] (as with [[pericarditis]]).
*[[Depressed PR segment|PR depression]]
* Variations in the [[amplitude]] or directionality of [[QRS complex|QRS]] from beat to beat and/or a low voltage [[QRS complex|QRS]]
 
[[File:ECG-Pericarditis.jpg|center|thumb|Widespread concave ST elevation and PR depression is present throughout the precordial (V2-6) and limb leads (I, II, aVL, aVF). Case Courtesy of Ed Burns <ref>https://litfl.com/wp-content/uploads/2018/08/ECG-Pericarditis.jpg</ref>]]
<br />
 
=== X-ray ===
The findings of [[Chest X-ray|chest x-ray]] in Dressler's syndrome may include: <ref name="pmid20511488">{{cite journal |vauthors=Khandaker MH, Espinosa RE, Nishimura RA, Sinak LJ, Hayes SN, Melduni RM, Oh JK |title=Pericardial disease: diagnosis and management |journal=Mayo Clin. Proc. |volume=85 |issue=6 |pages=572–93 |date=June 2010 |pmid=20511488 |pmc=2878263 |doi=10.4065/mcp.2010.0046 |url=}}</ref>
 
* Flattening of the [[costophrenic angle]]<nowiki/>s
 
* Enlargement of the cardiac silhouette (non-specific chamber enlargement).
 
=== Echocardiography or Ultrasound ===
 
*Echocardiography is used to:
**Confirm the presence of [[pericardial fluid]] and evaluate the potential risk of [[cardiac tamponade]].
**Evaluate ventricular contractility and the potential risk of [[congestive heart failure]].<ref name="pmid16553111">{{cite journal |vauthors=Wessman DE, Stafford CM |title=The postcardiac injury syndrome: case report and review of the literature |journal=South. Med. J. |volume=99 |issue=3 |pages=309–14 |date=March 2006 |pmid=16553111 |doi=10.1097/01.smj.0000203330.15503.0b |url=}}</ref>
*
 
=== CT scan ===
The findings of CT scan in Dressler's syndrome may include: <ref name="pmid5923769">{{cite journal| author=Levin EJ, Bryk D| title=Dressler syndrome (postmyocardial infarction syndrome). | journal=Radiology | year= 1966 | volume= 87 | issue= 4 | pages= 731-6 | pmid=5923769 | doi=10.1148/87.4.731 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=5923769  }}</ref>
 
*[[Pericardial effusion]] of varying size, which may be simple (serous) or more often complex ([[hemopericardium]])
* Myocardial thinning of the infarcted region
*[[Stent|Stents]] in the [[coronary arteries]] (e.g., post [[Percutaneous coronary intervention|PCI]]) may be present
 
=== MRI ===
The findings of MRI in Dressler's syndrome may include:
 
* Fluid collections in the [[pericardium]] (may become loculated).<ref name="pmid12972828">{{cite journal |vauthors=Scarfone RJ, Donoghue AJ, Alessandrini EA |title=Cardiac tamponade complicating postpericardiotomy syndrome |journal=Pediatr Emerg Care |volume=19 |issue=4 |pages=268–71 |date=August 2003 |pmid=12972828 |doi=10.1097/01.pec.0000092573.40174.74 |url=}}</ref>
 
* Intense late post-[[gadolinium]] enhancement of entire [[Pericardium|pericardium.]]<ref name="pmid19627595">{{cite journal| author=Steadman CD, Khoo J, Kovac J, McCann GP| title=Dressler's syndrome demonstrated by late gadolinium enhancement cardiovascular magnetic resonance. | journal=J Cardiovasc Magn Reson | year= 2009 | volume= 11 | issue=  | pages= 23 | pmid=19627595 | doi=10.1186/1532-429X-11-23 | pmc=2723097 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19627595  }}</ref>
* Regional thinning and akinesis of the infarcted myocardium.
 
=== Other Imaging Findings ===
There are no other imaging findings associated with Dressler's syndrome.
 
=== Other Diagnostic Studies ===
There are no other diagnostic studies associated with Dressler's syndrome.


==Treatment==
==Treatment==
Dressler's syndrome is typically treated with high dose (up to 650 mg PO q 4 to 6 hours) enteric-coated [[aspirin]].  Acetominophen can be added for pain management as this does not affect the coagulation system.  Anticoagulants should be discontinued if the patient develops a pericardial effusion.


[[Non-steroidal_anti-inflammatory_drug|NSAIDs]] such as [[ibuprofen]] should be avoided in the peri-infarct period as they:
===Medical Therapy===
#Increase the risk of [[reinfarction]]  
Dressler's syndrome is typically treated with high dose (up to 650 mg PO q 4 to 6 hours) enteric-coated [[aspirin]]. [[Acetaminophen]] can be added for pain management as this does not affect the coagulation system. [[Anticoagulant|Anticoagulants]] should be discontinued if the patient develops a [[pericardial effusion]].<ref name="pmid220377383">{{cite journal |vauthors=Jaworska-Wilczynska M, Abramczuk E, Hryniewiecki T |title=Postcardiac injury syndrome |journal=Med. Sci. Monit. |volume=17 |issue=11 |pages=CQ13–14 |date=November 2011 |pmid=22037738 |doi=10.12659/msm.882029 |url=}}</ref>
#Adversely impact left ventricular remodeling.
 
#Block the effectiveness of [[aspirin]]
'''"2017 Revised ESC Guidelines for the Management of ST-Elevation Myocardial Infarction (DO NOT EDIT)'''


===ACC/AHA Treatment Guidelines (DO NOT EDIT)<ref name="pmid15339869">{{cite journal |author=Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK |title=ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction) |journal=Circulation |volume=110 |issue=9 |pages=e82–292 |year=2004 |month=August |pmid=15339869 |doi= |url=http://circ.ahajournals.org/cgi/pmidlookup?view=long&pmid=15339869}}</ref>===
* Anti-inflammatory therapy is recommended in post-STEMI pericarditis as in post-cardiac injury pericardial syndromes for symptom relief and reduction of recurrences.
* Aspirin is recommended as first choice of anti-inflammatory therapy post-STEMI at a dose of 500–1000 mg every 6–8 h for 1–2 weeks, decreasing the total daily dose by 250–500 mg every 1–2 weeks in keeping with 2015 ESC Guidelines for the diagnosis and management of pericardial diseases.
* Colchicine is recommended as first-line therapy as an adjunct to aspirin/non-steroidal anti-inflammatory drug therapy (3 months) and is also recommended for the recurrent forms (6 months).
* Corticosteroids are not recommended due to the risk of scar thinning with aneurysm development or rupture.
* Pericardiocentesis is rarely required, except for cases of haemodynamic compromise with signs of tamponade".<ref name="pmid288866212">{{cite journal| author=Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H et al.| title=2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). | journal=Eur Heart J | year= 2018 | volume= 39 | issue= 2 | pages= 119-177 | pmid=28886621 | doi=10.1093/eurheartj/ehx393 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28886621  }}</ref>


{{cquote|
====2013 Revised ACCF/AHA Guidelines for the Management of ST-Elevation Myocardial Infarction====
====Class I====


1. [[Aspirin]] is recommended for treatment of [[pericarditis]] after [[STEMI]]. Doses as high as 650 mg orally (entericcoated) every 4 to 6 hours may be needed. ''(Level of Evidence: B)''
====Management of Pericarditis After STEMI ====


2. [[Anticoagulation]] should be immediately discontinued if pericardial effusion develops or increases. ''(Level of Evidence: C)''
{|class="wikitable"
|-
| colspan="1" style="text-align:center; background:LightGreen"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class I]]
|-
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''1.''' [[Aspirin]] is recommended for treatment of [[pericarditis]] after [[STEMI]].''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])''<nowiki>"</nowiki>
|}


====Class IIa====
{|class="wikitable"
|-
|colspan="1" style="text-align:center; background:LightCoral"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class III]] (Harm)
|-
|bgcolor="LightCoral"|<nowiki>"</nowiki>'''1.''' [[Glucocorticoids]] and [[nonsteroidal antiinflammatory]] drugs are potentially harmful for treatment of pericarditis after STEMI. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])''<nowiki>"</nowiki>
|}


1. For episodes of [[pericarditis]] after [[STEMI]] that are not adequately controlled with [[aspirin]], it is reasonable to administer 1 or more of the following:
{|class="wikitable"
:a. [[Colchicine]] 0.6 mg orally every 12 hours ''(Level of Evidence: B)''
|-
:b. [[Acetaminophen]] 500 mg orally every 6 hours. ''(Level of Evidence: C)''
| colspan="1" style="text-align:center; background:LemonChiffon"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class IIb]]
|-
|bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''1.''' Administration of [[acetaminophen]], [[colchicine]], or narcotic analgesics may be reasonable if aspirin, even in higher doses, is not effective. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])''<nowiki>"</nowiki>
|}


====Class IIb====
=== Surgery ===


1. [[Corticosteroid]]s might be considered only as a last resort in patients with [[pericarditis]] refractory to [[aspirin]] or [[NSAID]]s. Although [[corticosteroid]]s are effective for pain relief, their use is associated with an increased risk of scar thinning and [[myocardial rupture]]. ''(Level of Evidence: C)''
* No surgical intervention is recommended in the management of Dressler's syndrome.
*[[Pericardiocentesis]] is rarely required, except for cases of hemodynamic compromise with signs of [[Cardiac tamponade|tamponade]]<ref name="pmid287230173" />.


2. [[Nonsteroidal anti-inflammatory drug]]s may be considered for pain relief; however, they should not be used for extended periods because of their effect on [[platelet]] function, an increased risk of myocardial scar thinning, and infarct expansion. ''(Level of Evidence: B)''
=== Primary Prevention ===
Despite the lack of guidelines on the prevention of Dressler's syndrome, [[ST elevation myocardial infarction|MI]] patients with the aforementioned risk factors should be followed closely in the few weeks after the ischemic event for the early detection of signs of [[pericarditis]].


====Class III====
*


1. [[Ibuprofen]] should not be used for pain relief because it blocks the [[antiplatelet]] effect of [[aspirin]] and it can cause myocardial scar thinning and infarct expansion. ''(Level of Evidence: B)''
=== Secondary Prevention ===
}}


==Sources==
* Recurrence of Dressler's syndrome is common and [[relapse]]<nowiki/>s were reported up to 1 year following the event.
*The 2004 ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction <ref name="pmid15339869">{{cite journal |author=Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK |title=ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction) |journal=Circulation |volume=110 |issue=9 |pages=e82–292 |year=2004 |month=August |pmid=15339869 |doi= |url=http://circ.ahajournals.org/cgi/pmidlookup?view=long&pmid=15339869}}</ref>
* Some researchers suggest that [[intravenous immunoglobulin]] therapy has some benefit in resistant cases.<ref name="pmid25287461">{{cite journal| author=del Fresno MR, Peralta JE, Granados MÁ, Enríquez E, Domínguez-Pinilla N, de Inocencio J| title=Intravenous immunoglobulin therapy for refractory recurrent pericarditis. | journal=Pediatrics | year= 2014 | volume= 134 | issue= 5 | pages= e1441-6 | pmid=25287461 | doi=10.1542/peds.2013-3900 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25287461  }}</ref><br />


*The 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients with ST-Elevation Myocardial Infarction <ref name="pmid18071078">{{cite journal |author=Antman EM, Hand M, Armstrong PW, ''et al'' |title=2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee |journal=Circulation |volume=117 |issue=2 |pages=296–329 |year=2008 |month=January |pmid=18071078 |doi=10.1161/CIRCULATIONAHA.107.188209 |url=}}</ref>


==References==
==References==
Line 107: Line 271:
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
[[Category:Best pages]]


[[Category:Cardiology]]
[[Category:Cardiology]]

Latest revision as of 19:37, 13 January 2020

WikiDoc Resources for Dressler's syndrome

Articles

Most recent articles on Dressler's syndrome

Most cited articles on Dressler's syndrome

Review articles on Dressler's syndrome

Articles on Dressler's syndrome in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Dressler's syndrome

Images of Dressler's syndrome

Photos of Dressler's syndrome

Podcasts & MP3s on Dressler's syndrome

Videos on Dressler's syndrome

Evidence Based Medicine

Cochrane Collaboration on Dressler's syndrome

Bandolier on Dressler's syndrome

TRIP on Dressler's syndrome

Clinical Trials

Ongoing Trials on Dressler's syndrome at Clinical Trials.gov

Trial results on Dressler's syndrome

Clinical Trials on Dressler's syndrome at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Dressler's syndrome

NICE Guidance on Dressler's syndrome

NHS PRODIGY Guidance

FDA on Dressler's syndrome

CDC on Dressler's syndrome

Books

Books on Dressler's syndrome

News

Dressler's syndrome in the news

Be alerted to news on Dressler's syndrome

News trends on Dressler's syndrome

Commentary

Blogs on Dressler's syndrome

Definitions

Definitions of Dressler's syndrome

Patient Resources / Community

Patient resources on Dressler's syndrome

Discussion groups on Dressler's syndrome

Patient Handouts on Dressler's syndrome

Directions to Hospitals Treating Dressler's syndrome

Risk calculators and risk factors for Dressler's syndrome

Healthcare Provider Resources

Symptoms of Dressler's syndrome

Causes & Risk Factors for Dressler's syndrome

Diagnostic studies for Dressler's syndrome

Treatment of Dressler's syndrome

Continuing Medical Education (CME)

CME Programs on Dressler's syndrome

International

Dressler's syndrome en Espanol

Dressler's syndrome en Francais

Business

Dressler's syndrome in the Marketplace

Patents on Dressler's syndrome

Experimental / Informatics

List of terms related to Dressler's syndrome

For patient information click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdelrahman Ibrahim Abushouk, MD[2]; Mohammed A. Sbeih, M.D.[3]; Cafer Zorkun, M.D., Ph.D. [4]; Nabeel Ahmed, M.B.B.S

WikiDoc Resources for Dressler's syndrome

Articles

Most recent articles on Dressler's syndrome

Most cited articles on Dressler's syndrome

Review articles on Dressler's syndrome

Articles on Dressler's syndrome in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Dressler's syndrome

Images of Dressler's syndrome

Photos of Dressler's syndrome

Podcasts & MP3s on Dressler's syndrome

Videos on Dressler's syndrome

Evidence Based Medicine

Cochrane Collaboration on Dressler's syndrome

Bandolier on Dressler's syndrome

TRIP on Dressler's syndrome

Clinical Trials

Ongoing Trials on Dressler's syndrome at Clinical Trials.gov

Trial results on Dressler's syndrome

Clinical Trials on Dressler's syndrome at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Dressler's syndrome

NICE Guidance on Dressler's syndrome

NHS PRODIGY Guidance

FDA on Dressler's syndrome

CDC on Dressler's syndrome

Books

Books on Dressler's syndrome

News

Dressler's syndrome in the news

Be alerted to news on Dressler's syndrome

News trends on Dressler's syndrome

Commentary

Blogs on Dressler's syndrome

Definitions

Definitions of Dressler's syndrome

Patient Resources / Community

Patient resources on Dressler's syndrome

Discussion groups on Dressler's syndrome

Patient Handouts on Dressler's syndrome

Directions to Hospitals Treating Dressler's syndrome

Risk calculators and risk factors for Dressler's syndrome

Healthcare Provider Resources

Symptoms of Dressler's syndrome

Causes & Risk Factors for Dressler's syndrome

Diagnostic studies for Dressler's syndrome

Treatment of Dressler's syndrome

Continuing Medical Education (CME)

CME Programs on Dressler's syndrome

International

Dressler's syndrome en Espanol

Dressler's syndrome en Francais

Business

Dressler's syndrome in the Marketplace

Patents on Dressler's syndrome

Experimental / Informatics

List of terms related to Dressler's syndrome

Synonyms and keywords: Postmyocardial infarction syndrome; PMIS; Post-cardiac injury syndrome

Overview

Dressler's syndrome or post-myocardial infarction syndrome is a form of pericarditis that occurs in the setting of myocardial infarction. It typically occurs 2 to 10 weeks after myocardial infarction. Dressler's syndrome results from an autoimmune inflammatory reaction to myocardial neo-antigens. Possible complications include pericardial effusion, cardiac tamponade, and constrictive pericarditis; however, the prognosis is usually favorable with early treatment. The diagnostic criteria of Dressler's syndrome depend on pleuritic chest pain, pericardial friction rub, ECG changes, and echocardiography-detected pericardial effusion. The recommended medical treatments include aspirin and colchicine.

Historical Perspective

  • Dressler's syndrome was first characterized by William Dressler in 1956.
  • It should not be confused with the Dressler's syndrome of hemoglobinuria, named after Lucas Dressler who characterized it in 1854.[1][2][3]

Classification

  • There is no established system for the classification of Dressler's syndrome.

Pathophysiology

Gross Pathology

Gross pathological examination may show the following findings: [6]

The epicardium was characterized by a fine granular layer on its surface with a “bread and butter” appearance, particularly at the level of the atrial regions and the cardiac apex in a case of Dressler's syndrome. [7]


Microscopic Pathology

Microscopic examination of the myocardial tissue sections may show: [8]

Causes

The common causes of Dressler's syndrome include: [9]

Differentiating Dressler's Syndrome from other Diseases

  • Dressler's syndrome typically occurs 2 to 10 weeks after a myocardial infarction has occurred.[10][11]
  • This differentiates Dressler's syndrome from:
  • Dressler's syndrome should be differentiated from:

Epidemiology and Demographics

  • Incidence: In the setting of myocardial infarction, Dressler's syndrome was classically reported to occur in about 3 to 4% of MI cases.[12]
  • However, the incidence has markedly decreased in the reperfusion era (between 0.5 to 2%), presumably because of smaller infarct sizes.[13]
  • Age: Dressler's syndrome occurs more often in younger age groups.
  • Gender: There is no gender predilection for Dressler's syndrome.
  • Race: There is no racial predilection for Dressler's syndrome.
  • Mortality rate: The prognosis is usually favorable with early treatment with a low mortality rate.

Risk Factors

  • The risk of Dressler's syndrome increases with the size of the infarction.
  • Further, a former episode of Dressler's syndrome increases the risk of relapse upon recurrent MI (the most important risk factor).
  • Epidemiological studies showed a higher risk ratio of Dressler's syndrome with: [14]

Screening

  • There is insufficient evidence to recommend routine screening for Dressler's syndrome.

Natural History, Complications, and Prognosis

Natural History

Complications

The complications of Dressler's syndrome may include: [16]

Prognosis

Diagnosis

Diagnostic Study of Choice

"2017 Revised ESC Guidelines for the Management of ST-Elevation Myocardial Infarction (DO NOT EDIT)

Diagnostic criteria do not differ from those for acute pericarditis including two of the following criteria: (i) pleuritic chest pain (85–90% of cases); (ii) pericardial friction rub (≤ 33% of cases); (iii) ECG changes (≤ 60% of cases), with new widespread ST-segment elevation, usually mild and progressive, or PR depression in the acute phase; and (iv) pericardial effusion (≤ 60% of cases and generally mild)".[17]

History and Symptoms

The syndrome consists of a persistent low-grade fever and chest pain which is usually pleuritic in nature.The symptoms enlisted below tend to occur after a few weeks or even months after myocardial infarction and tend to subside in a few days: [18]

Physical Examination

Physical examination of patients with Dressler's syndrome may show[16]:

Laboratory Findings

The laboratory work-up of patients with Dressler's syndrome may include: [16]

Electrocardiogram

An ECG may demonstrate: [19]

Widespread concave ST elevation and PR depression is present throughout the precordial (V2-6) and limb leads (I, II, aVL, aVF). Case Courtesy of Ed Burns [20]


X-ray

The findings of chest x-ray in Dressler's syndrome may include: [21]

  • Enlargement of the cardiac silhouette (non-specific chamber enlargement).

Echocardiography or Ultrasound

CT scan

The findings of CT scan in Dressler's syndrome may include: [23]

MRI

The findings of MRI in Dressler's syndrome may include:

Other Imaging Findings

There are no other imaging findings associated with Dressler's syndrome.

Other Diagnostic Studies

There are no other diagnostic studies associated with Dressler's syndrome.

Treatment

Medical Therapy

Dressler's syndrome is typically treated with high dose (up to 650 mg PO q 4 to 6 hours) enteric-coated aspirin. Acetaminophen can be added for pain management as this does not affect the coagulation system. Anticoagulants should be discontinued if the patient develops a pericardial effusion.[26]

"2017 Revised ESC Guidelines for the Management of ST-Elevation Myocardial Infarction (DO NOT EDIT)

  • Anti-inflammatory therapy is recommended in post-STEMI pericarditis as in post-cardiac injury pericardial syndromes for symptom relief and reduction of recurrences.
  • Aspirin is recommended as first choice of anti-inflammatory therapy post-STEMI at a dose of 500–1000 mg every 6–8 h for 1–2 weeks, decreasing the total daily dose by 250–500 mg every 1–2 weeks in keeping with 2015 ESC Guidelines for the diagnosis and management of pericardial diseases.
  • Colchicine is recommended as first-line therapy as an adjunct to aspirin/non-steroidal anti-inflammatory drug therapy (3 months) and is also recommended for the recurrent forms (6 months).
  • Corticosteroids are not recommended due to the risk of scar thinning with aneurysm development or rupture.
  • Pericardiocentesis is rarely required, except for cases of haemodynamic compromise with signs of tamponade".[27]

2013 Revised ACCF/AHA Guidelines for the Management of ST-Elevation Myocardial Infarction

Management of Pericarditis After STEMI

Class I
"1. Aspirin is recommended for treatment of pericarditis after STEMI.(Level of Evidence: B)"
Class III (Harm)
"1. Glucocorticoids and nonsteroidal antiinflammatory drugs are potentially harmful for treatment of pericarditis after STEMI. (Level of Evidence: B)"
Class IIb
"1. Administration of acetaminophen, colchicine, or narcotic analgesics may be reasonable if aspirin, even in higher doses, is not effective. (Level of Evidence: B)"

Surgery

  • No surgical intervention is recommended in the management of Dressler's syndrome.
  • Pericardiocentesis is rarely required, except for cases of hemodynamic compromise with signs of tamponade[16].

Primary Prevention

Despite the lack of guidelines on the prevention of Dressler's syndrome, MI patients with the aforementioned risk factors should be followed closely in the few weeks after the ischemic event for the early detection of signs of pericarditis.

Secondary Prevention

  • Recurrence of Dressler's syndrome is common and relapses were reported up to 1 year following the event.
  • Some researchers suggest that intravenous immunoglobulin therapy has some benefit in resistant cases.[28]


References

  1. Template:WhoNamedIt
  2. L. A. Dressler. Ein Fall von intermittirender Albuminurie und Chromaturie. Archiv für pathologische Anatomie und Physiologie und für klinische Medicin, 1854, 6: 264-266.
  3. DRESSLER W (1956). "A post-myocardial infarction syndrome; preliminary report of a complication resembling idiopathic, recurrent, benign pericarditis". J Am Med Assoc. 160 (16): 1379–83. PMID 13306560.
  4. Engle MA, Zabriskie JB, Senterfit LB (1976). "Heart-reactive antibody, viral illness, and the postpericardiotomy syndrome. Correlates of a triple-blind, prospective study". Trans Am Clin Climatol Assoc. 87: 147–60. PMC 2441394. PMID 785768.
  5. Jerjes-Sánchez C, Ramírez-Rivera A, Ibarra-Pérez C (1996). "The Dressler syndrome after pulmonary embolism". Am J Cardiol. 78 (3): 343–5. PMID 8759817.
  6. Feola A, De Stefano N, Della Pietra B (2015). "Pericarditis Epistenocardica or Dressler Syndrome? An Autopsy Case". Case Rep Med. 2015: 215340. doi:10.1155/2015/215340. PMC 4512600. PMID 26240567.
  7. https://www.hindawi.com/journals/crim/2015/215340/fig1//
  8. Feola A, De Stefano N, Della Pietra B (2015). "Pericarditis Epistenocardica or Dressler Syndrome? An Autopsy Case". Case Rep Med. 2015: 215340. doi:10.1155/2015/215340. PMC 4512600. PMID 26240567.
  9. "StatPearls". 2019. PMID 28723017.
  10. 10.0 10.1 Krainin F, Flessas A, Spodick D (1984). "Infarction-associated pericarditis. Rarity of diagnostic electrocardiogram". N Engl J Med. 311 (19): 1211–4. PMID 6493274.
  11. Krainin F, Flessas A, Spodick D (1984). "Infarction-associated pericarditis. Rarity of diagnostic electrocardiogram". N Engl J Med. 311 (19): 1211–4. PMID 6493274.
  12. Krainin F, Flessas A, Spodick D (1984). "Infarction-associated pericarditis. Rarity of diagnostic electrocardiogram". N Engl J Med. 311 (19): 1211–4. PMID 6493274.
  13. Tofler GH, Muller JE, Stone PH, Willich SN, Davis VG, Poole WK; et al. (1989). "Pericarditis in acute myocardial infarction: characterization and clinical significance". Am Heart J. 117 (1): 86–92. PMID 2643287.
  14. "StatPearls". 2019. PMID 28723017.
  15. Engle MA, Zabriskie JB, Senterfit LB (1976). "Heart-reactive antibody, viral illness, and the postpericardiotomy syndrome. Correlates of a triple-blind, prospective study". Trans Am Clin Climatol Assoc. 87: 147–60. PMC 2441394. PMID 785768.
  16. 16.0 16.1 16.2 16.3 "StatPearls". 2019. PMID 28723017.
  17. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H; et al. (2018). "2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)". Eur Heart J. 39 (2): 119–177. doi:10.1093/eurheartj/ehx393. PMID 28886621.
  18. Wessman DE, Stafford CM (2006). "The postcardiac injury syndrome: case report and review of the literature". South Med J. 99 (3): 309–14. doi:10.1097/01.smj.0000203330.15503.0b. PMID 16553111.
  19. Hendry C, Liew CK, Chauhan A, Zacharias J (2012). "A life-saving case of Dressler's syndrome". Eur Heart J Acute Cardiovasc Care. 1 (3): 232–5. doi:10.1177/2048872612452319. PMC 3760538. PMID 24062911.
  20. https://litfl.com/wp-content/uploads/2018/08/ECG-Pericarditis.jpg
  21. Khandaker MH, Espinosa RE, Nishimura RA, Sinak LJ, Hayes SN, Melduni RM, Oh JK (June 2010). "Pericardial disease: diagnosis and management". Mayo Clin. Proc. 85 (6): 572–93. doi:10.4065/mcp.2010.0046. PMC 2878263. PMID 20511488.
  22. Wessman DE, Stafford CM (March 2006). "The postcardiac injury syndrome: case report and review of the literature". South. Med. J. 99 (3): 309–14. doi:10.1097/01.smj.0000203330.15503.0b. PMID 16553111.
  23. Levin EJ, Bryk D (1966). "Dressler syndrome (postmyocardial infarction syndrome)". Radiology. 87 (4): 731–6. doi:10.1148/87.4.731. PMID 5923769.
  24. Scarfone RJ, Donoghue AJ, Alessandrini EA (August 2003). "Cardiac tamponade complicating postpericardiotomy syndrome". Pediatr Emerg Care. 19 (4): 268–71. doi:10.1097/01.pec.0000092573.40174.74. PMID 12972828.
  25. Steadman CD, Khoo J, Kovac J, McCann GP (2009). "Dressler's syndrome demonstrated by late gadolinium enhancement cardiovascular magnetic resonance". J Cardiovasc Magn Reson. 11: 23. doi:10.1186/1532-429X-11-23. PMC 2723097. PMID 19627595.
  26. Jaworska-Wilczynska M, Abramczuk E, Hryniewiecki T (November 2011). "Postcardiac injury syndrome". Med. Sci. Monit. 17 (11): CQ13–14. doi:10.12659/msm.882029. PMID 22037738.
  27. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H; et al. (2018). "2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)". Eur Heart J. 39 (2): 119–177. doi:10.1093/eurheartj/ehx393. PMID 28886621.
  28. del Fresno MR, Peralta JE, Granados MÁ, Enríquez E, Domínguez-Pinilla N, de Inocencio J (2014). "Intravenous immunoglobulin therapy for refractory recurrent pericarditis". Pediatrics. 134 (5): e1441–6. doi:10.1542/peds.2013-3900. PMID 25287461.

See also


de:Dressler-Syndrom


Template:WikiDoc Sources